- A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. Dutcher, J.P., Creekmore, S., Weiss, G.R., Margolin, K., Markowitz, A.B., Roper, M., Parkinson, D., Ciobanu, N., Fisher, R.I., Boldt, D.H. J. Clin. Oncol. (1989)